E&L Failure during FDA inspection: what inspectors expect and how to fix it


Published on 30/12/2025

E&L Study Failures: Strategies to Satisfy FDA Inspectors

Extractables and leachables (E&L) testing has become an integral part of pharmaceutical manufacturing, particularly in relation to product safety and regulatory compliance. When failures in E&L studies occur, particularly during FDA inspections, it raises significant concerns for both manufacturers and regulators. This article will guide you through systematic approaches to identify and resolve E&L failures, ensuring compliance with current Good Manufacturing Practices (GMP).

By focusing on a structured investigation process, this article aims to equip you with actionable insights into identifying signals, collecting relevant data, exploring potential causes, implementing corrective actions, and reinforcing your quality assurance frameworks. After reading, you will be prepared to address E&L compliance failures with a systematic investigation methodology that aligns with regulatory expectations.

Symptoms/Signals on the Floor or in the Lab

Identifying the symptoms of E&L failure is critical to initiating the response process. Signals may manifest in various forms, as outlined below:

  • Out-of-Specification (OOS) Results: E&L testing results that exceed predefined acceptable limits.
  • Deviations: Any departure from established protocols
or standard operating procedures (SOPs) during the E&L investigation.
  • Customer Complaints: Reports from end-users indicating unexpected reactions or side effects likely linked to packaging materials.
  • Inspection Findings: Direct observations from regulatory inspectors highlighting concerns specifically related to E&L data discrepancies.
  • Promptly recognizing these symptoms can save time in the investigation phase and help ensure all potential sources are considered right from the onset.

    Likely Causes

    E&L failures can arise from multiple categories of potential causes, which should be meticulously examined during an investigation:

    Category Example Causes
    Materials Inadequate characterization of materials, use of non-compliant materials.
    Method Incorrect or outdated testing methods, improper sample preparation.
    Machine Equipment malfunction, calibration issues.
    Man Inadequate staff training, failure to follow procedures.
    Measurement Poor instrument performance, lack of validation of testing methods.
    Environment Contaminated testing environment, poor air quality controls.

    Conducting a root cause analysis requires exploration into each of these areas to ensure comprehensive coverage of potential failure modes.

    Immediate Containment Actions (first 60 minutes)

    In the initial response phase, immediate containment actions must prioritize safeguarding the manufacturing process and protecting product integrity. Actions may include:

    • Segregation of Affected Batches: Clearly identify and isolate affected lots, ensuring they are not used in distribution.
    • Re-evaluation of E&L Testing: Conduct a rapid review of testing protocols, ensure all conditions were met during initial evaluations.
    • Deployment of Temporary Holds: Implement holds on production lines or warehouses until further analysis is complete.
    • Triage for Affected Materials: Assess raw materials sourced from the same supplier to identify potential systemic issues.

    Documenting all actions taken during this period is crucial for compliance and for reinforcing CAPA measures later on.

    Investigation Workflow

    An effective investigation requires a structured approach to collect and analyze relevant data. The following components should be included in your workflow:

    1. **Data Collection:**
    – Gather all relevant batch records, testing protocols, and associated documentation.
    – Collect data from all involved departments (Manufacturing, QC, QA).
    – Review prior OOS or deviation reports for patterns.

    2. **Data Interpretation:**
    – Conduct a cross-functional review of data to identify correlations or inconsistencies that could indicate root causes.
    – Use statistical analysis where applicable to understand deviations from expected outcomes.

    3. **Stakeholder Engagement:**
    – Involve cross-functional teams early in the process to ensure comprehensive understanding and ownership of the issues.
    – Schedule regular updates to maintain clarity on progress and findings.

    These steps ensure a methodical investigation, preventing oversight and enhancing problem resolution.

    Root Cause Tools

    To determine the root cause of E&L failures, various analytical tools can be employed, including:

    • 5-Why Analysis: A method that involves asking “why” multiple times (typically five) to trace the root cause of a problem. Use this tool when the cause is not immediately obvious.
    • Fishbone Diagram: Also known as Ishikawa or cause-and-effect diagrams, this tool helps categorize potential causes related to E&L findings into components (Materials, Methods, Machines, etc.).
    • Fault Tree Analysis: A deductive failure analysis that uses Boolean logic to combine a variety of lower-level events into one or more higher-level events. Best suited for complex systems.

    Choosing the right tool depends on the complexity of the failure and the team’s familiarity with the technique.

    CAPA Strategy

    Effective Corrective and Preventive Actions (CAPA) must be put in place to address the root causes identified in the investigation phase and prevent recurrence:

    • Correction: Immediate actions taken to rectify the specific incident, such as re-testing affected batches or recalibrating equipment.
    • Corrective Action: Actions designed to eliminate the root cause of the deviation. This may involve retraining staff, redesigning test protocols, or sourcing new materials.
    • Preventive Action: These measures prevent future occurrences and may include improved material specifications, supplier audits, or enhancements to environmental controls.

    Documenting CAPA processes and outcomes reinforces compliance and demonstrates a commitment to quality improvement.

    Control Strategy & Monitoring

    A robust control strategy is vital for maintaining product quality. Monitor the following:

    • Statistical Process Control (SPC): Use SPC techniques to detect potential deviations in real time by monitoring critical parameters throughout production.
    • Trending and Sampling: Establish regular trending reports on E&L data to catch deviations early. Implement routine sampling schedules for high-risk materials.
    • Alarms and Alerts: Utilize automated alarm systems to prompt immediate investigation when critical thresholds are breached.
    • Verification: Regularly verify control systems and corrective action outcomes to ensure their effectiveness.

    Integrating these components into your quality management system enhances stability and product integrity.

    Validation / Re-qualification / Change Control Impact

    Changes resulting from E&L failure investigations may necessitate validation, re-qualification, or change control measures. Key steps include:

    • Validation of New Methods: If any alteration to E&L testing methods is made, ensure they are validated according to established guidelines.
    • Re-qualification of Equipment: Calibration and requalification of affected machines are crucial to maintaining compliance.
    • Change Control Documentation: Any changes in processes or materials as part of the investigation must be documented thoroughly through formal change control procedures.

    These actions ensure that all modifications are compliant and thoroughly vetted, providing transparency and evidence for regulatory reviews.

    Inspection Readiness: What Evidence to Show

    During an inspection, being prepared with the right documentation is critical. Highlight:

    • Records and Logs: Maintain comprehensive records of all testing, investigations, and findings related to E&L and deviations.
    • Batch Documentation: Ensure all batch records are complete and accessible, demonstrating compliance with established protocols.
    • Deviation Documentation: Keep a detailed log of all OOS and deviations, including root cause analyses and the effectiveness of CAPA measures.

    Documentation integrity can contribute significantly to establishing credibility during an FDA, EMA, or MHRA inspection.

    FAQs

    What are E&L failures?

    E&L failures occur when extractables and leachables testing yields results exceeding acceptable limits, indicating potential risks associated with product safety.

    How can I signal an E&L failure?

    Common signals include OOS results, customer complaints, and direct findings from regulatory inspectors.

    What immediate actions should I take upon identifying an E&L failure?

    Isolate affected batches, reevaluate E&L testing methods, implement production holds, and assess linked raw materials.

    Related Reads

    What tools can aid in root cause analysis?

    Common tools include 5-Why analysis, Fishbone diagrams, and Fault Tree analysis, depending on complexity.

    How can I ensure compliance with CAPA strategies?

    Focus on correction, corrective actions, and preventive strategies, documenting all measures taken to eliminate root causes.

    What is the role of control strategy in E&L compliance?

    A strong control strategy helps in monitoring ongoing compliance through SPC, trending data, and corrective design measures.

    Will changes after a failure necessitate validation?

    Yes, any modifications to processes or materials after an E&L failure should undergo validation or requalification processes.

    What documentation is critical during inspections?

    Ensure comprehensive records of testing, investigations, batch documentation, and logs of deviations are readily available for inspectors.

    Pharma Tip:  Software Validation Gap after device supplier change: batch release impact and documentation pack